MetLife, Inc. $MET Shares Sold by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. trimmed its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 37.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,706 shares of the financial services provider's stock after selling 23,345 shares during the period. Northwestern Mutual Wealth Management Co.'s holdings in MetLife were worth $3,193,000 at the end of the most recent reporting period.

• 2 Insurance Stocks Poised For Major Breakouts

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MET. Quaker Wealth Management LLC increased its position in MetLife by 198.2% during the 2nd quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider's stock worth $27,000 after purchasing an additional 672 shares in the last quarter. MTM Investment Management LLC acquired a new stake in MetLife during the second quarter worth approximately $37,000. GFG Capital LLC purchased a new stake in MetLife in the 2nd quarter worth approximately $38,000. Abound Wealth Management raised its holdings in MetLife by 652.3% in the 2nd quarter. Abound Wealth Management now owns 489 shares of the financial services provider's stock valued at $39,000 after acquiring an additional 424 shares during the last quarter. Finally, Legend Financial Advisors Inc. acquired a new position in MetLife in the 2nd quarter valued at $40,000. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Up 1.5%

Shares of NYSE MET opened at $77.45 on Thursday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.18 and a current ratio of 0.18. MetLife, Inc. has a 1 year low of $65.21 and a 1 year high of $88.09. The stock's 50-day simple moving average is $78.78 and its 200-day simple moving average is $78.71. The firm has a market cap of $51.03 billion, a price-to-earnings ratio of 14.58, a PEG ratio of 0.73 and a beta of 0.76.

• MarketBeat Week in Review – 8/21 - 8/25

MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The financial services provider reported $2.37 EPS for the quarter, beating analysts' consensus estimates of $2.30 by $0.07. The firm had revenue of $17.90 billion for the quarter, compared to the consensus estimate of $18.64 billion. MetLife had a net margin of 5.30% and a return on equity of 21.00%. The firm's revenue was down 5.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.95 EPS. As a group, equities analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 4th will be given a $0.5675 dividend. The ex-dividend date of this dividend is Tuesday, November 4th. This represents a $2.27 annualized dividend and a yield of 2.9%. MetLife's dividend payout ratio (DPR) is currently 42.75%.

Analyst Upgrades and Downgrades

• This Insurance Giant Looks Ready For A Breakout

A number of equities research analysts have recently commented on MET shares. Wolfe Research raised MetLife to a "strong-buy" rating in a research report on Tuesday, September 16th. Barclays lifted their price target on MetLife from $93.00 to $98.00 and gave the company an "overweight" rating in a report on Wednesday, October 8th. Weiss Ratings lowered shares of MetLife from a "buy (b-)" rating to a "hold (c+)" rating in a report on Monday. Cowen reissued a "buy" rating on shares of MetLife in a research report on Friday, August 22nd. Finally, Jefferies Financial Group upped their price target on shares of MetLife from $100.00 to $103.00 and gave the stock a "buy" rating in a research report on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $94.60.

Read Our Latest Research Report on MET

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

• Five stocks we like better than MetLife
• Growth Stocks: What They Are, Examples and How to Invest
• 3 Stocks Poised to Benefit From Google’s AI Breakthough
• NYSE Stocks Give Investors a Variety of Quality Options
• Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
• What is a buyback in stocks? A comprehensive guide for investors
• 3 Stocks You’ll Wish You Bought Before 2026

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here